Ikarian Capital, LLC Global Blood Therapeutics, Inc. Call Options Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $7.79 Million - $10.2 Million	-200,000 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$37.65 - $63.77 $1.13 Million - $1.91 Million	-30,000 Reduced 13.04%	200,000 $8.66 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $6.82 Million - $11.5 Million	140,000 Added 155.56%	230,000 $14.5 Million
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $417,200 - $872,000	-10,000 Reduced 10.0%	90,000 $4.6 Million
Q4 2019 Jan 31, 2020	BUY	$45.7 - $81.86 $4.57 Million - $8.19 Million	100,000 New	100,000 $7.95 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.